Search

Search Constraints

You searched for: Author/Creator Goldschmidt, Neta

Search Results

21. Polymorphisms in the human organic cation transporter and the multidrug resistance gene: correlation with imatinib levels and clinical course in patients with chronic myeloid leukemia. Issue 11 (November 2014)

22. Polymorphisms in the human organic cation transporter and the multidrug resistance gene: correlation with imatinib levels and clinical course in patients with chronic myeloid leukemia. Issue 11 (November 2014)

24. Predictive value of the CLL‐IPI in CLL patients receiving chemo‐immunotherapy as first‐line treatment. (6th September 2018)

26. Primary peg-filgrastim prophylaxis versus filgrastim given "on demand" for neutropenia during therapy with cladribine for hairy cell leukemia. (July 2019)

27. Progressive refractory light chain amyloidosis and multiple myeloma patients are responsive to the addition of clarithromycin to IMiD based therapy. Issue 2 (21st November 2016)

29. Richter's transformation to diffuse large B‐cell lymphoma: A retrospective study reporting clinical data, outcome, and the benefit of adding rituximab to chemotherapy, from the Israeli CLL Study Group. Issue 11 (2nd September 2014)

30. Rituximab, methotrexate, procarbazine and lomustine (R-MPL) for the treatment of primary Central nervous system lymphoma. Issue 9 (29th July 2022)